3-193637282-G-T
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_130837.3(OPA1):c.1035+1G>T variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000691 in 1,447,636 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_130837.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant optic atrophy, classic formInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
- optic atrophyInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathyInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
- OPA1-related optic atrophy with or without extraocular featuresInheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
- Behr syndromeInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- mitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type)Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AR Classification: MODERATE Submitted by: ClinGen
- autosomal dominant optic atrophy plus syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| OPA1 | NM_130837.3 | c.1035+1G>T | splice_donor_variant, intron_variant | Intron 10 of 30 | ENST00000361510.8 | NP_570850.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| OPA1 | ENST00000361510.8 | c.1035+1G>T | splice_donor_variant, intron_variant | Intron 10 of 30 | 5 | NM_130837.3 | ENSP00000355324.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.91e-7 AC: 1AN: 1447636Hom.: 0 Cov.: 25 AF XY: 0.00000139 AC XY: 1AN XY: 720940 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
This sequence change affects a donor splice site in intron 8 of the OPA1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in OPA1 are known to be pathogenic (PMID: 11440988, 20157015, 20952381, 25012220). This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant is also known as c.1035+1G. Disruption of this splice site has been observed in individuals with dominant optical atrophy (PMID: 33884488, 34242285). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at